Clinical trial
S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage…
NCT00085501 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00085501 |
|---|---|
| Title | S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer |
| Official title | Phase II Selection Design Trial Of Concurrent Chemotherapy + Cetuximab Vs. Chemotherapy Followed By Cetuximab In Advanced Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | cetuximab, carboplatin, paclitaxel |
| Enrollment | 242 |
| Start date | Jul 1, 2004 |
| Primary completion | Aug 1, 2007 |
| Completion | Jul 1, 2011 |
| First posted | Jun 11, 2004 |
| Last update posted | Nov 1, 2012 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: